Generic tenofovir licensed in South Africa
4 May 2007. Related: Treatment access.
Treatment access
Agreement for generic license of darunavir in South Africa
4 May 2007. Related: Treatment access.
Brazil issues plans to produce generic efavirenz
4 May 2007. Related: Treatment access.
Access to Abbott drugs in Thailand
4 May 2007. Related: Treatment access.
Indian government only plans to provide access to second-line ARVs after first-line drug treatment targets are met
4 May 2007. Related: Treatment access.
Increasing antiretroviral access for children
4 May 2007. Related: Treatment access, Paediatric care.
Abbott situation worsens in Thailand
4 April 2007. Related: Treatment access.
Wall Street Journal examines reason Abbott increased price of ritonavir
5 February 2007. Related: Treatment access.
Access to treatment in the USA: waiting list for ARVs in South Carolina
5 February 2007. Related: Treatment access.
Royalty-free license granted for development of tenofovir and topical microbicide
5 February 2007. Related: Treatment access, Vaccines and microbicides.
Novartis test case in India threatens the ARV pharmacy of the developing world
5 February 2007. Related: Treatment access.
Thailand issues compulsory license to manufacture lopinavir/r: WHO criticised for challenging this essential access to treatment
5 February 2007. Related: Treatment access.
Global Fund Board selects new executive director
5 February 2007. Related: Treatment access.
Clinton price for new paediatric treatment
6 December 2006. Related: Treatment access.
Indian generic heat-stable ritonavir
6 December 2006. Related: Treatment access.
Generic FDC of efavirenz/tenofovir/FTC launched by Cipla
6 December 2006. Related: Treatment access.
Compulsory license for efavirenz in Thailand
6 December 2006. Related: Treatment access.
Gilead licenses tenofovir to Indian generic manufacturers
7 October 2006. Related: Treatment access.
Funding prospects improve for Round 6 Global Fund
7 October 2006. Related: Treatment access.
Enough is enough: South African activists demand: fire Manto
10 September 2006. Related: Conference reports, Treatment access.
Treatment access: more optimistic results from scale up programmes
10 September 2006. Related: Conference reports, Treatment access.
Treatment access and community responses: online webcasts and debates
9 September 2006. Related: Conference reports, Treatment access.
Patent oppositions filed on three essential drugs
9 September 2006. Related: Treatment access.
Activists meet with Gilead and Abbott over access to second-line therapy
3 August 2006. Related: Treatment access.
Data exclusivity: a new threat to affordable generic medicines
3 August 2006. Related: Treatment access.
ITPC publish updated report on access to treatment
10 June 2006. Related: Treatment access.
Protesters evicted from UN headquarters, New York
10 June 2006. Related: Treatment access.
Community opposition filed against tenofovir patent application in India
10 June 2006. Related: Treatment access.
Lopinavir/r (meltrex) filed in South Africa
12 May 2006. Related: Treatment access.
Indian community organisations file first opposition against patent application
12 May 2006. Related: Treatment access.
ITPC Indian Mailbox database now online
12 May 2006. Related: Treatment access.
Global fund review: timing of Round 6 still unclear
12 May 2006. Related: Treatment access.
Treatment access new from Aidspan
9 April 2006. Related: Treatment access.
China puts 23 HIV/AIDS patients under house arrest
9 April 2006. Related: Treatment access.
TAC wins court case against Matthias Rath
26 March 2006. Related: Treatment access.
BMS licenses atazanavir to generic drug companies
7 March 2006. Related: Treatment access.
Missing the target: a report on HIV/AIDS treatment access from the frontlines
9 February 2006. Related: Treatment access.
New Clinton agreements to lower prices of HIV/AIDS rapid tests and second-line drugs in 50 countries
9 February 2006. Related: Treatment access.
WHO adds seven antiretrovirals to list of prequalified HIV drugs
9 February 2006. Related: Treatment access.
Ranbaxy launches two new ARVs in India
9 February 2006. Related: Treatment access.
FDA tentative approvals: generic oral solutions of nevirapine and d4T
9 February 2006. Related: Treatment access.
Amendment to WTO TRIPS agreement makes access to affordable medicines even more bleak: MSF expresses concern that patients the world-over will have to pay the price
9 February 2006. Related: Treatment access.
WTO uses AIDS patients to cover up development round failure
9 February 2006. Related: Treatment access.
Brazil’s deal with Abbott is challenged in courts
13 December 2005. Related: Treatment access.
Depletion of latent HIV-1 reservoir with valproic acid: interesting data but not a cure
13 October 2005. Related: Treatment access, Cure-related research, Basic science and immunology.
Does WHO clinical stage reliably predict who should receive ARV treatment?
14 September 2005. Related: Conference reports, Treatment access.
Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
14 September 2005. Related: Conference reports, Treatment access.
Global Fund commitment to $175M annually in 2006, 2007
14 September 2005. Related: Treatment access.
Forty injured, ten shot at peaceful protest to demand treatment in South Africa
14 August 2005. Related: Treatment access.
FDA approve additional Indian generics
14 August 2005. Related: Treatment access.
Medical innovation and patent gridlock
14 August 2005. Related: Treatment access.
Six Indian generic ARVs are given FDA tentative approval
14 July 2005. Related: Treatment access.
Methadone and buprenorphine added to WHO list of essential medicines
14 July 2005. Related: Treatment access.
MSF’s pricing guide to purchasing ARVs: 8th edition online
14 July 2005. Related: Treatment access.
WHO 3 by 5 progress report
14 July 2005. Related: Treatment access.
MSF criticises Brazilian government for failing to break antiretroviral patents
15 June 2005. Related: Treatment access.
Russian activists imprisoned for asking for treatment – letters of support requested
15 June 2005. Related: Treatment access.
Millions in Global Fund grants go unused: Indian government bureaucracies kill off people living with AIDS
15 May 2005. Related: Treatment access.
Demand for two originator ARVs could soon exceed supply
18 April 2005. Related: Treatment access.
Indian patent bill is introduced with no change: the beginning of the end of generics?
18 April 2005. Related: Treatment access.
Patent mailbox opened in India
18 April 2005. Related: Treatment access.
GSK calls on UK to use G8 presidency to enforce patents
18 April 2005. Related: Treatment access.
India admitted into Bush aid programme in same week that Indian parliament dismantles hope of future generic ARVs
18 April 2005. Related: Treatment access.
Community advocates meet with Indian generic companies: 2nd World CAB meeting
29 March 2005. Related: Treatment access.
AIDS activists concerned over drug prices post-patent
29 March 2005. Related: Treatment access.